Novartis AG
SIX:NOVN

Watchlist Manager
Novartis AG Logo
Novartis AG
SIX:NOVN
Watchlist
Price: 87.68 CHF 1.11% Market Closed
Market Cap: 171.5B CHF
Have any thoughts about
Novartis AG?
Write Note

Intrinsic Value

The intrinsic value of one NOVN stock under the Base Case scenario is 97.92 CHF. Compared to the current market price of 87.68 CHF, Novartis AG is Undervalued by 10%.

The Intrinsic Value is calculated as the average of DCF and Relative values:

NOVN Intrinsic Value
97.92 CHF
Undervaluation 10%
Intrinsic Value
Price
Worst Case
Base Case
Best Case

Valuation History
Novartis AG

Intrinsic Value History
Dive into the past to invest in the future

Uncover deeper insights with the Valuation History. Learn how current stock valuations stack up against historical averages to gauge true investment potential.

Start now and learn if your stock is truly undervalued or overvalued!

Start Valuation
Backtest Conclusion
Very Attractive
Current Valuation
+45%
Avg Valuation
-12%
Worst Valuation
-49%
Best Valuation
+45%

Stock is trading at its lowest valuation over the past 5 years.

Backtest Example
NOVN
Valuation History
HIDDEN
Show
Valuation History Unavailable

Historical valuation for NOVN cannot be conducted due to limitations such as insufficient data or other constraints.

Valuation In Progress...
Valuation In Progress...
How do you feel about NOVN?
Bearish
Neutral
Bullish

Fundamental Analysis

87.68 CHF
+1.11%
+1.11%
Benchmark
Company Quality
No Indicators Selected
Select Indicators

Select up to 3 indicators:

Insider Trading
0-3
Months
0-6
Months
0-12
Months
0-36
Months
No Periods Selected
Select Periods

Select up to 2 periods:

Novartis AG
CH
Pharmaceuticals
Market Cap
171.5B CHF
IPO
May 7, 2001
Employees
104 323
Switzerland
Market Cap
171.5B CHF
Industry
Pharmaceuticals
IPO
May 7, 2001
Company Overview
Loading...
Business Segments
Loading...
Economic Moat
Loading...
Earnings Call
Loading...
Management
Loading...
Contacts
Loading...
AI Assistant
AI Assistant
Ask me anything about Novartis AG

Provide an overview of the primary business activities
of Novartis AG.

What unique competitive advantages
does Novartis AG hold over its rivals?

What risks and challenges
does Novartis AG face in the near future?

Has there been any significant insider trading activity
in Novartis AG recently?

Summarize the latest earnings call
of Novartis AG.

Is it considered overvalued or undervalued
based on the latest financial data?

Show all valuation multiples
for Novartis AG.

Provide P/S
for Novartis AG.

Provide P/E
for Novartis AG.

Provide P/OCF
for Novartis AG.

Provide P/FCFE
for Novartis AG.

Provide P/B
for Novartis AG.

Provide EV/S
for Novartis AG.

Provide EV/GP
for Novartis AG.

Provide EV/EBITDA
for Novartis AG.

Provide EV/EBIT
for Novartis AG.

Provide EV/OCF
for Novartis AG.

Provide EV/FCFF
for Novartis AG.

Provide EV/IC
for Novartis AG.

Show me price targets
for Novartis AG made by professional analysts.

What are the Revenue projections
for Novartis AG?

How accurate were the past Revenue estimates
for Novartis AG?

What are the Net Income projections
for Novartis AG?

How accurate were the past Net Income estimates
for Novartis AG?

What are the EPS projections
for Novartis AG?

How accurate were the past EPS estimates
for Novartis AG?

What are the EBIT projections
for Novartis AG?

How accurate were the past EBIT estimates
for Novartis AG?

Compare the revenue forecasts
for Novartis AG with those of its competitors based on recent analyst estimates.

Compare the intrinsic valuations
of Novartis AG and its key competitors using the latest financial data.

Compare historical revenue growth rates
of Novartis AG against its competitors.

Analyze the profit margins
(gross, operating, and net) of Novartis AG compared to its peers.

Compare the P/E ratios
of Novartis AG against its peers.

Discuss the investment returns and shareholder value creation
comparing Novartis AG with its peers.

Analyze the financial leverage
of Novartis AG compared to its main competitors.

Show all profitability ratios
for Novartis AG.

Provide ROE
for Novartis AG.

Provide ROA
for Novartis AG.

Provide ROIC
for Novartis AG.

Provide ROCE
for Novartis AG.

Provide Gross Margin
for Novartis AG.

Provide Operating Margin
for Novartis AG.

Provide Net Margin
for Novartis AG.

Provide FCF Margin
for Novartis AG.

Show all solvency ratios
for Novartis AG.

Provide D/E Ratio
for Novartis AG.

Provide D/A Ratio
for Novartis AG.

Provide Interest Coverage Ratio
for Novartis AG.

Provide Altman Z-Score Ratio
for Novartis AG.

Provide Quick Ratio
for Novartis AG.

Provide Current Ratio
for Novartis AG.

Provide Cash Ratio
for Novartis AG.

What is the historical Revenue growth
over the last 5 years for Novartis AG?

What is the historical Net Income growth
over the last 5 years for Novartis AG?

What is the current Free Cash Flow
of Novartis AG?

Discuss the annual earnings per share (EPS)
trend over the past five years for Novartis AG.

Financials
Annual
Quarterly
TTM
Annual
Quarterly
TTM

Balance Sheet Decomposition
Novartis AG

Current Assets 26.4B
Cash & Short-Term Investments 9.6B
Receivables 8.3B
Other Current Assets 8.6B
Non-Current Assets 67.9B
Long-Term Investments 2.6B
PP&E 10.5B
Intangibles 49.3B
Other Non-Current Assets 5.4B
Current Liabilities 29.3B
Accounts Payable 4.1B
Other Current Liabilities 25.2B
Non-Current Liabilities 25.4B
Long-Term Debt 18.7B
Other Non-Current Liabilities 6.7B
Efficiency

Earnings Waterfall
Novartis AG

Revenue
49.9B USD
Cost of Revenue
-12.5B USD
Gross Profit
37.5B USD
Operating Expenses
-22.2B USD
Operating Income
15.3B USD
Other Expenses
2.3B USD
Net Income
17.6B USD

Free Cash Flow Analysis
Novartis AG

Last Value
3-Years Average
FCF Margin
Conversion Rate
Fundamental Scores

NOVN Profitability Score
Profitability Due Diligence

Novartis AG's profitability score is 70/100. The higher the profitability score, the more profitable the company is.

Positive Gross Profit
Positive Free Cash Flow
Exceptional 3-Year Average ROE
Exceptional ROE
70/100
Profitability
Score

Novartis AG's profitability score is 70/100. The higher the profitability score, the more profitable the company is.

NOVN Solvency Score
Solvency Due Diligence

Novartis AG's solvency score is 67/100. The higher the solvency score, the more solvent the company is.

High Interest Coverage
High Altman Z-Score
Low D/E
Long-Term Solvency
67/100
Solvency
Score

Novartis AG's solvency score is 67/100. The higher the solvency score, the more solvent the company is.

Wall St
Price Targets

NOVN Price Targets Summary
Novartis AG

Wall Street analysts forecast NOVN stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for NOVN is 105.29 CHF with a low forecast of 82.82 CHF and a high forecast of 130.2 CHF.

Lowest
Price Target
82.82 CHF
6% Downside
Average
Price Target
105.29 CHF
20% Upside
Highest
Price Target
130.2 CHF
48% Upside
View Analyst Estimates
View Analyst Estimates
Want to learn more about Wall St estimates for NOVN?

Click here to dive deeper.

Dividends

Dividend Yield
Lowest
Average
Highest
Dividend Per Share
N/A
Growth 3Y
Growth 5Y
Growth 10Y
Dividend Safety Score
Very
Unsafe
Unsafe
Safe
Very
Safe
0
25
50
75
100
Shareholder Yield

Current shareholder yield for NOVN is .

Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?

Shareholder Yield
Dividend Yield
Lowest
Average
Highest
Buyback Yield
Lowest
Average
Highest
Debt Paydown Yield
Lowest
Average
Highest

Ownership

NOVN Insider Trading
Buy and sell transactions by insiders

Cumulative Transactions Amount
Period Sold Bought Net
3 Months
6 Months
9 Months
12 Months
Why is insider trading important?

NOVN News

Other Videos

See Also

Discover More
What is the Intrinsic Value of one NOVN stock?

The intrinsic value of one NOVN stock under the Base Case scenario is 97.92 CHF.

Is NOVN stock undervalued or overvalued?

Compared to the current market price of 87.68 CHF, Novartis AG is Undervalued by 10%.

Back to Top